Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€4.00
Target price
07.05.26
€7.05
Performance (%)
56.25%
Price
12.12.25
€6.15
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Myriad Genetics has seen massive gains of 56.25%. This prediction currently runs until 07.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 0.820% | 0.820% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $14.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat